二尖瓣经导管缘对缘修复术的院内结局及二尖瓣手术再入院趋势：2018 - 2020年国家再入院数据库
Mitral Transcatheter Edge-to-Edge Repair In-Hospital Outcomes and Mitral Valve Surgery Readmission Trends: National Readmission Database 2018-2020.
作者信息
Akkawi Abdul Rahman, Zaid Syed, Hatab Taha, Bou Chaaya Rody G, Oundo Emmanuel, Faza Nadeen, Little Stephen H, Atkins Marvin D, Reardon Michael J, Zoghbi William A, Kleiman Neal S, Goel Sachin S
机构信息
Department of Internal Medicine, University of Kansas School of Medicine, Wichita, Kansas.
Department of Cardiology, College of Medicine, Michael E. DeBakey VA Medical Center, Houston, Texas.
出版信息
Struct Heart. 2024 Jul 27;9(2):100350. doi: 10.1016/j.shj.2024.100350. eCollection 2025 Feb.
•Study design: Utilized the National Readmission Database from 2018-2020. The study included patients over 18 years of age who underwent transcatheter edge-to-edge repair and analyzed readmission for mitral valve (MV) surgery within 180 days.•Readmission rate: Only 1.1% of patients who underwent transcatheter edge-to-edge repair required MV surgery within 180 days.•Mortality and morbidity: In-hospital mortality after MV surgery was 9.7%, with a high incidence of acute kidney injury (51%) and bleeding events (15.7%) among readmitted patients.•Trend over time: The readmission rate for MV surgery significantly declined from 1.8% in 2018 to 0.8% in 2020.•Predictors of readmission: Younger age was identified as an independent predictor of readmission for MV surgery.
•研究设计：使用了2018 - 2020年的国家再入院数据库。该研究纳入了18岁以上接受经导管缘对缘修复术的患者，并分析了180天内二尖瓣（MV）手术的再入院情况。
•再入院率：接受经导管缘对缘修复术的患者中，只有1.1%在180天内需要进行MV手术。
•死亡率和发病率：MV手术后的住院死亡率为9.7%，再入院患者中急性肾损伤（51%）和出血事件（15.7%）的发生率较高。
•随时间变化趋势：MV手术的再入院率从2018年的1.8%显著下降至2020年的0.8%。
•再入院的预测因素：年龄较小被确定为MV手术再入院的独立预测因素。
Zotero 插件